Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Inositol is a compound found in many foods and supplements that may boost health and manage certain diseases. Learn what it ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...

Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Nearly 40 generic medications targeting heart and brain illnesses produced by Glenmark Pharmaceuticals have been recalled by ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.